English

GLYCOGENESYS INC

EDGAR

Quarterly report (10-Q) · filed 2005-11-16

48 filing records in this dataset, filed from 1996-05-20 to 2005-11-16. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

391 thousand USD

2000-09-30 · USD

Exact inputs and evidence

Revenue: 390943 USD Source

Operating margin

-682.19%

2000-09-30 · %

Exact inputs and evidence

Operating Income: -2666959 USD Source
Revenue: 390943 USD Source

Operating cash flow

-3.02 million USD

2000-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -10073472 USD Source
Operating Cash Flow: -7051241 USD Source

Free cash flow

-3.05 million USD

2000-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -10073472 USD Source
Operating Cash Flow: -7051241 USD Source
Capital Expenditure: 137848 USD Source
Capital Expenditure: 109764 USD Source

Cash and cash equivalents: 2 million USD 2005-09-30 Source
Exact value

1999374 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-8.93 million USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Net income: -10124716 USD · 2004-01-01 – 2004-12-31 Source
Net income: -7945561 USD · 2004-01-01 – 2004-09-30 Source
Net income: -2508968 USD · 2005-01-01 – 2005-03-31 Source
Net income: -2083514 USD · 2005-04-01 – 2005-06-30 Source
Net income: -2159451 USD · 2005-07-01 – 2005-09-30 Source

Capital expenditure

21.5 thousand USD

2004-10-01 – 2005-09-30

Exact inputs and evidence

Capital expenditure: 176769 USD · 2004-01-01 – 2004-12-31 Source
Capital expenditure: 173689 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 13940 USD · 2005-01-01 – 2005-03-31 Source
Capital expenditure: 16393 USD · 2005-01-01 – 2005-06-30 Source
Capital expenditure: 13940 USD · 2005-01-01 – 2005-03-31 Source
Capital expenditure: 18375 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 16393 USD · 2005-01-01 – 2005-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-11-16.

Financial data available through: 2004-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 1997-12-31
Operating income: 10 of 11 periods available· newest 2004-12-31
Net income: 10 of 11 periods available· newest 2004-12-31
Operating cash flow: 3 of 11 periods available· newest 1998-12-31
Capital expenditure: 9 of 11 periods available· newest 2004-12-31
Total assets: 10 of 11 periods available· newest 2004-12-31
liabilities: No compatible figures in this window
Current assets: 10 of 11 periods available· newest 2004-12-31
Current liabilities: 10 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 2.5 million

Prior period

−USD 7.62 million

2003-01-01 – 2003-12-31
Current period

−USD 10.12 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-10124716 − -7622201 = -2502515 USD

-7622201 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-10124716 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GLYCOGENESYS INC · 2004-12-31 GLYCOGENESYS INC (edgar:946661) Year-over-year change in Net income: -2502515 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -10124716 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#6966 Input fundies:NetIncome: -7622201 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#6966
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-1.2%

Prior period

USD 178,836

2003-01-01 – 2003-12-31
Current period

USD 176,769

2004-01-01 – 2004-12-31

Exact inputs and evidence

176769 − 178836 = -2067 USD

178836 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
176769 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GLYCOGENESYS INC · 2004-12-31 GLYCOGENESYS INC (edgar:946661) Year-over-year change in Capital expenditure: -2067 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 176769 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#7204 Input fundies:CapitalExpenditure: 178836 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#7204
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Operating cash flow.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1997 1997-01-01 – 1997-12-31

Revenue USD 0
Operating costs Derived USD 4.82 million
Operating income −USD 4.82 million
Tax, interest and other Derived −USD 83,618
Net income −USD 4.73 million

Cash

Operating cash flow −USD 2.38 million
Capital expenditure USD 39,744
Free cash flow Derived −USD 2.42 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	646821 Derived	-646821	29012 Derived	-675833	Unavailable	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -646821 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -675833 USD Inspect Net Income Open source
1996 1996-01-01 – 1996-12-31	2213152 Derived	-2213152	86995 Derived	-2300147	-1715818 Derived	Source 1996-01-01 – 1996-12-31: 0 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -2213152 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -2300147 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -1696134 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 19684 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	4818093 Derived	-4818093	-83618 Derived	-4734475	-2415881 Derived	Source 1997-01-01 – 1997-12-31: 0 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -4818093 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -4734475 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -2376137 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 39744 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 1997

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
19951995-12-31	Revenue	Revenue: 0 Open source
19961996-12-31	Revenue	Revenue: 0 Open source
19971997-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19971997-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	Not reported	Operating Income: -646821 Open source Revenue: 0 Open source
19961996-12-31	Operating margin	Not reported	Operating Income: -2213152 Open source Revenue: 0 Open source
19971997-12-31	Operating margin	Not reported	Operating Income: -4818093 Open source Revenue: 0 Open source
19951995-12-31	Net margin	Not reported	Net Income: -675833 Open source Revenue: 0 Open source
19961996-12-31	Net margin	Not reported	Net Income: -2300147 Open source Revenue: 0 Open source
19971997-12-31	Net margin	Not reported	Net Income: -4734475 Open source Revenue: 0 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1696134 Open source Capital Expenditure: 19684 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2376137 Open source Capital Expenditure: 39744 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -2.4M 1997

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	Not reported	No source recorded
19961996-12-31	Operating cash flow	-1696134	Operating Cash Flow: -1696134 Open source
19971997-12-31	Operating cash flow	-2376137	Operating Cash Flow: -2376137 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -2.4M 1997

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	Unavailable	No source recorded
19961996-12-31	Free cash flow	-1715818	Operating Cash Flow: -1696134 Open source Capital Expenditure: 19684 Open source
19971997-12-31	Free cash flow	-2415881	Operating Cash Flow: -2376137 Open source Capital Expenditure: 39744 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Liabilities / assets	Not reported	Total Assets: 308337 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 488839 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 2906737 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.7× 1997

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	0.5×	Current Assets: 289330 Open source Current Liabilities: 579278 Open source
19961996-12-31	Current assets / current liabilities	2.43×	Current Assets: 463063 Open source Current Liabilities: 190748 Open source
19971997-12-31	Current assets / current liabilities	5.7×	Current Assets: 2644392 Open source Current Liabilities: 463617 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1995 1995-01-01 – 1995-12-31	−USD 675,833 Exact value Exact value: -675833 USD 1995-01-01 – 1995-12-31: -675833 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 1995-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -675833 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -675833 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-98-000003.txt#1629 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 2.3 million Exact value Exact value: -2300147 USD 1996-01-01 – 1996-12-31: -2300147 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 1996-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -2300147 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2300147 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#1729 The citation records this snapshot. The page link may show a newer release later.	−USD 1.7 million Exact value Exact value: -1696134 USD 1996-01-01 – 1996-12-31: -1696134 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLYCOGENESYS INC · 1996-12-31 GLYCOGENESYS INC (edgar:946661) Operating Cash Flow: -1696134 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1696134 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-98-000003.txt#2061 The citation records this snapshot. The page link may show a newer release later.	USD 19,684 Exact value Exact value: 19684 USD 1996-01-01 – 1996-12-31: 19684 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 1996-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 19684 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19684 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-98-000003.txt#2064 The citation records this snapshot. The page link may show a newer release later.	−USD 1.72 million Calculation and evidence -1696134 − 19684 USD Exact free cash flow: -1715818 USD 1996-01-01 – 1996-12-31: -1696134 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 19684 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLYCOGENESYS INC · 1996-12-31 GLYCOGENESYS INC (edgar:946661) Free cash flow: -1715818 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1696134 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-98-000003.txt#2061 Input fundies:CapitalExpenditure: 19684 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-98-000003.txt#2064 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 4.73 million Exact value Exact value: -4734475 USD 1997-01-01 – 1997-12-31: -4734475 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 1997-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -4734475 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4734475 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2356 The citation records this snapshot. The page link may show a newer release later.	−USD 2.38 million Exact value Exact value: -2376137 USD 1997-01-01 – 1997-12-31: -2376137 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLYCOGENESYS INC · 1997-12-31 GLYCOGENESYS INC (edgar:946661) Operating Cash Flow: -2376137 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2376137 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2371 The citation records this snapshot. The page link may show a newer release later.	USD 39,744 Exact value Exact value: 39744 USD 1997-01-01 – 1997-12-31: 39744 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 1997-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 39744 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39744 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2374 The citation records this snapshot. The page link may show a newer release later.	−USD 2.42 million Calculation and evidence -2376137 − 39744 USD Exact free cash flow: -2415881 USD 1997-01-01 – 1997-12-31: -2376137 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 39744 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLYCOGENESYS INC · 1997-12-31 GLYCOGENESYS INC (edgar:946661) Free cash flow: -2415881 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2376137 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2371 Input fundies:CapitalExpenditure: 39744 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2374 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 6.47 million Exact value Exact value: -6473505 USD 1998-01-01 – 1998-12-31: -6473505 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 1998-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -6473505 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6473505 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000914760-01-000063.txt#1863 The citation records this snapshot. The page link may show a newer release later.	−USD 4.49 million Exact value Exact value: -4493349 USD 1998-01-01 – 1998-12-31: -4493349 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GLYCOGENESYS INC · 1998-12-31 GLYCOGENESYS INC (edgar:946661) Operating Cash Flow: -4493349 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4493349 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2371 The citation records this snapshot. The page link may show a newer release later.	USD 205,188 Exact value Exact value: 205188 USD 1998-01-01 – 1998-12-31: 205188 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 1998-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 205188 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 205188 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000914760-01-000063.txt#1888 The citation records this snapshot. The page link may show a newer release later.	−USD 4.7 million Calculation and evidence -4493349 − 205188 USD Exact free cash flow: -4698537 USD 1998-01-01 – 1998-12-31: -4493349 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 205188 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GLYCOGENESYS INC · 1998-12-31 GLYCOGENESYS INC (edgar:946661) Free cash flow: -4698537 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4493349 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000946661-99-000001.txt#2371 Input fundies:CapitalExpenditure: 205188 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000914760-01-000063.txt#1888 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 12.3 million Exact value Exact value: -12301718 USD 1999-01-01 – 1999-12-31: -12301718 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 1999-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -12301718 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12301718 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000927016-02-003087.txt#2405 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 364,450 Exact value Exact value: 364450 USD 1999-01-01 – 1999-12-31: 364450 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 1999-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 364450 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 364450 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000927016-02-003087.txt#2430 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 17.27 million Exact value Exact value: -17270311 USD 2000-01-01 – 2000-12-31: -17270311 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 2000-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -17270311 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17270311 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000927016-03-001791.txt#4437 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 138,913 Exact value Exact value: 138913 USD 2000-01-01 – 2000-12-31: 138913 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 2000-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 138913 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 138913 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0000927016-03-001791.txt#4704 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 22.73 million Exact value Exact value: -22726163 USD 2001-01-01 – 2001-12-31: -22726163 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 2001-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -22726163 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22726163 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-04-053850.txt#4650 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 16,733 Exact value Exact value: 16733 USD 2001-01-01 – 2001-12-31: 16733 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 2001-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 16733 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16733 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-04-053850.txt#4902 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 10.11 million Exact value Exact value: -10114177 USD 2002-01-01 – 2002-12-31: -10114177 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 2002-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -10114177 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10114177 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#6966 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 177,662 Exact value Exact value: 177662 USD 2002-01-01 – 2002-12-31: 177662 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 2002-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 177662 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 177662 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#7204 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 7.62 million Exact value Exact value: -7622201 USD 2003-01-01 – 2003-12-31: -7622201 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 2003-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -7622201 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7622201 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#6966 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 178,836 Exact value Exact value: 178836 USD 2003-01-01 – 2003-12-31: 178836 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 2003-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 178836 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 178836 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#7204 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 10.12 million Exact value Exact value: -10124716 USD 2004-01-01 – 2004-12-31: -10124716 USD Inspect Net Income Open source Share or cite Citation for Net Income · GLYCOGENESYS INC · 2004-12-31 GLYCOGENESYS INC (edgar:946661) Net Income: -10124716 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10124716 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#6966 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 176,769 Exact value Exact value: 176769 USD 2004-01-01 – 2004-12-31: 176769 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GLYCOGENESYS INC · 2004-12-31 GLYCOGENESYS INC (edgar:946661) Capital Expenditure: 176769 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:05:05Z Snapshot: 3758bf38ea01465a2a343a1445d0dcbc4f855cd7624af11b28e60dd4ffbf441b Dimensions: Consolidated View: https://fundies.io/companies/edgar/946661/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 176769 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/946661/0001193125-05-064946.txt#7204 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

48 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000946661, 946661, edgar:946661

Also known as GLYCOGENESY INC, IGG INTERNATIONAL INC, SAFESCIENCE INC

GLYCOGENESYS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Capital expenditure

Company performance

What changed year over year

Net income

Capital expenditure

Where revenue goes

1997 1997-01-01 – 1997-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation